Page 1. Characterization of Reversible Kinase Inhibitors using Microfluidic
Mobility-Shift Assays Introduction Current drug discovery ...
Mobility-Shift Assays Introduction Current drug discovery ...
- 16 Jun 2010
... of protein kinase inhibitors ... 4), and there are a number of kinase inhibitors
which target this inactive state, such as sorafenib (Fig. ...
which target this inactive state, such as sorafenib (Fig. ...
- 16 Jun 2010
... will substantially reduce the cancer mortality rate. Kinase Inhibitors. As
scientists continue to unravel the mechanisms underlining ...
scientists continue to unravel the mechanisms underlining ...
47k - 21 Jul 2010
... will substantially reduce the cancer mortality rate. Kinase Inhibitors. As
scientists continue to unravel the mechanisms underlining ...
scientists continue to unravel the mechanisms underlining ...
47k - 21 Jul 2010
Kinase inhibitors constitute an important new class of cancer drugs, whose selective
efficacy is largely determined by underlying tumor cell genetics. ...
efficacy is largely determined by underlying tumor cell genetics. ...
47k - 25 May 2010
... of modern drug discovery as target selectivity and specificity are common problems
in the identification and development of candidate kinase inhibitors. ...
in the identification and development of candidate kinase inhibitors. ...
50k - 4 Jun 2010
... discovery The successful kinase inhibitors are highly selective Kinase
profiling is very important for drug development process! ...
profiling is very important for drug development process! ...
- 16 Jun 2010
8. Publication
... Identification of genotype-correlated sensitivity to selective kinase inhibitors
by using high-throughput tumor cell line profiling. ...
by using high-throughput tumor cell line profiling. ...
48k - 25 May 2010
... three kinase inhibitors (SP600125,SU11248, andLY333531) reported by Fabian
et al. 13 (Figure 1) to have DAPK inhibition activity. ...
et al. 13 (Figure 1) to have DAPK inhibition activity. ...
- 16 Jun 2010
... EMD Merck, Discovery & Development of Next Generation Kinase Inhibitors
at ArQule Dennis France, Arqule Corporation, “Channeling ...
at ArQule Dennis France, Arqule Corporation, “Channeling ...
101k
Results Pages: 1 2 3 4 5 Next >>
